Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
Exemplary Fragrances: A Manual for Notorious Scents- What's going around right now? COVID, flu, stomach bug on the rise
- First SpaceX booster for upgraded Starship fails during test in Texas
- Mobility exercises are an important part of fitness as we age. Here are some tips
- Is new Harry Styles music on the way? Fans think so, after a cryptic website and posters pop up.
- The Tradition of Stone: A Gander at Notable Structures Through the Ages
- KJ Apa stars as Jimmy Stewart in new biopic: See his transformation
- Building an Individual Brand: Illustrations from Powerhouses
- China bans storing cremated remains in empty 'bone ash apartments'
